Reply to Feng, "Recalculation of inhibitor concentration fold-changes for CMY-219: comments on a recent article about CMY-219 conferring resistance to ceftazidime-avibactam".

IF 4.2 2区医学 Q2 MICROBIOLOGY

Antimicrobial Agents and Chemotherapy Pub Date : 2026-08-05 Epub Date: 2026-06-24 DOI:10.1128/aac.00523-26

Agnès B Jousset, Delphine Girlich, Saoussen Oueslati, Aurélien Birer, Anne Delaval, Caroline Guyot, Ines Rezzoug, Cécile Emeraud, Thierry Naas, Rémy A Bonnin, Laurent Dortet

引用次数: 0

查看原文本刊更多论文

回复冯，“CMY-219抑制剂浓度折线变化的重新计算：关于CMY-219对头孢他啶-阿维巴坦耐药的评论”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Antimicrobial Agents and Chemotherapy 医学-微生物学

CiteScore

10.00

自引率

8.20%

发文量

762

审稿时长

3 months

期刊介绍： Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.